US Stock MarketDetailed Quotes

XNCR Xencor

Watchlist
  • 24.130
  • +0.120+0.50%
Close Dec 20 16:00 ET
  • 24.130
  • 0.0000.00%
Post 16:15 ET
1.69BMarket Cap-7.59P/E (TTM)

About Xencor Company

Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Monrovia, CA.

Company Profile

SymbolXNCR
Company NameXencor
Listing DateDec 3, 2013
Issue Price5.50
Founded1997
CEODr. Bassil I. Dahiyat, PhD.
MarketNASDAQ
Employees256
Fiscal Year Ends12-31
Address465 North Halstead Street,Suite 200
CityPasadena
ProvinceCalifornia
CountryUnited States of America
Zip Code91016
Phone1-626-305-5900
Websitehttp://www.xencor.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Bassil I. Dahiyat, PhD.
  • Director, President and Chief Executive Officer
  • 7.97M
  • Bart Jan Cornelissen
  • Senior Vice President and Chief Financial Officer
  • --
  • John R. Desjarlais, PhD
  • Executive Vice President, Research and Chief Scientific Officer
  • 3.21M
  • Dr. Nancy K. Valente, M.D.
  • Executive Vice President and Chief Development Officer
  • 5.17M
  • Celia E. Eckert
  • Senior Vice President, General Counsel and Corporate Secretary
  • 2.02M
  • Dagmar Rosa-Bjorkeson, M.B.A.,M.S.
  • Independent Director
  • 346.25K
  • Dr. Ellen G. Feigal, M.D.
  • Independent Director
  • 348.00K
  • Richard J. Ranieri
  • Independent Director
  • 347.02K
  • Kurt A. Gustafson
  • Independent Director
  • 346.50K
  • Dr. A. Bruce Montgomery
  • Lead Independent Director
  • 384.19K
  • Dr. Kevin C. Gorman,PhD
  • Independent Director
  • 342.50K
  • Dr. Barbara Klencke, M.D.
  • Independent Director
  • 162.11K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List